Indirect comparison of different adjuvant chemotherapies for stage II-III gastric cancer after D2 gastrectomy in Asian patients / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
; (12): 534-537, 2013.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-357195
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To compare efficacy of different adjuvant chemotherapy regimens for stage II-III gastric cancer after D2 gastrectomy in Asian patients.</p><p><b>METHODS</b>Associated literatures were searched through electronic databases and hand-searching. Prospective randomized clinical trials (RCTs) comparing adjuvant chemotherapy after D2 gastrectomy with surgery alone were included in the study. Overall survival and disease-free survival were chosen as the endpoints. Relative hazard was analyzed by Bucher adjusted indirect comparison.</p><p><b>RESULTS</b>Two RCTs were selected, including comparison between S-1 versus surgery alone and comparison between XELOX versus surgery alone. There was no statistical difference in overall survival between the two regimens (HR=0.94, 95%CI0.62-1.44, P=0.79). The recurrence risk of S-1 was slightly higher as compared to XELOX, but no statistical difference was found (HR=1.11, 95%CI0.80-1.53, P=0.54).</p><p><b>CONCLUSION</b>The adjuvant chemotherapy with S-1 is similar to XELOX for stage II-III gastric cancer after D2 gastrectomy in Asian patients.</p>
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Postoperative Care
/
Stomach Neoplasms
/
General Surgery
/
Antineoplastic Combined Chemotherapy Protocols
/
Randomized Controlled Trials as Topic
/
Treatment Outcome
/
Chemotherapy, Adjuvant
/
Deoxycytidine
/
Drug Therapy
/
Fluorouracil
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Gastrointestinal Surgery
Year:
2013
Document type:
Article